Stay updated on Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Publications section now lists the NEJM article by Murthy et al. on tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer with full author names and citation details. The previous NEJM entry that included an erratum has been removed.
    Difference
    0.0%
    Check dated 2026-05-20T06:48:22.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added a new revision label v3.5.3 and removed the previous v3.5.2, indicating an updated release version on the page. This appears to be a meta-level update rather than a change to study details or content.
    Difference
    0.0%
    Check dated 2026-04-28T08:12:37.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page’s displayed revision version was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-21T03:12:40.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Publication reference in the Publications section was updated: the NEJM 2020 Tucatinib paper is added and the prior NEJM citation is removed.
    Difference
    0.0%
    Check dated 2026-04-14T02:26:12.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0. No trial content or user-facing information was changed.
    Difference
    0.0%
    Check dated 2026-03-23T13:38:46.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-08T23:55:07.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.